1. Home
  2. LAB vs GNE Comparison

LAB vs GNE Comparison

Compare LAB & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • GNE
  • Stock Information
  • Founded
  • LAB 1999
  • GNE 2011
  • Country
  • LAB United States
  • GNE United States
  • Employees
  • LAB N/A
  • GNE N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • GNE Power Generation
  • Sector
  • LAB Industrials
  • GNE Utilities
  • Exchange
  • LAB Nasdaq
  • GNE Nasdaq
  • Market Cap
  • LAB 449.9M
  • GNE 407.6M
  • IPO Year
  • LAB 2011
  • GNE N/A
  • Fundamental
  • Price
  • LAB $1.23
  • GNE $14.66
  • Analyst Decision
  • LAB Hold
  • GNE
  • Analyst Count
  • LAB 2
  • GNE 0
  • Target Price
  • LAB $1.35
  • GNE N/A
  • AVG Volume (30 Days)
  • LAB 1.5M
  • GNE 106.0K
  • Earning Date
  • LAB 11-04-2025
  • GNE 11-03-2025
  • Dividend Yield
  • LAB N/A
  • GNE 2.06%
  • EPS Growth
  • LAB N/A
  • GNE 49.43
  • EPS
  • LAB N/A
  • GNE 0.18
  • Revenue
  • LAB $169,737,000.00
  • GNE $483,284,000.00
  • Revenue This Year
  • LAB N/A
  • GNE $14.60
  • Revenue Next Year
  • LAB N/A
  • GNE $8.64
  • P/E Ratio
  • LAB N/A
  • GNE $79.72
  • Revenue Growth
  • LAB 79.77
  • GNE 13.12
  • 52 Week Low
  • LAB $0.92
  • GNE $13.05
  • 52 Week High
  • LAB $2.25
  • GNE $28.47
  • Technical
  • Relative Strength Index (RSI)
  • LAB 48.04
  • GNE 38.69
  • Support Level
  • LAB $1.16
  • GNE $14.45
  • Resistance Level
  • LAB $1.26
  • GNE $15.83
  • Average True Range (ATR)
  • LAB 0.07
  • GNE 0.59
  • MACD
  • LAB 0.01
  • GNE -0.02
  • Stochastic Oscillator
  • LAB 72.50
  • GNE 44.49

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Share on Social Networks: